BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36840612)

  • 1. Conditional relative survival in nonmetastatic esophagogastric cancer between 2006 and 2020: A population-based study.
    Pape M; Kuijper SC; Vissers PAJ; Ruurda JP; Neelis KJ; van Laarhoven HWM; Verhoeven RHA
    Int J Cancer; 2023 Jun; 152(12):2503-2511. PubMed ID: 36840612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities.
    Deng W; Yang Z; Dong X; Yu R; Wang W
    Cancer Med; 2021 Jan; 10(2):659-674. PubMed ID: 33314798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma.
    Shin DW; Kim HK; Cho J; Lee G; Cho J; Yoo JE; Shin S; Choi YS; Shim YM; Zo JI
    Ann Surg; 2022 Aug; 276(2):e86-e92. PubMed ID: 33086317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional survival in patients treated for gastric cancer with a curative intent.
    Ayloor Seshadri R; Soman AC; Aggrawal A; Karnawat A; Patidar S; Swaminathan R
    J Surg Oncol; 2023 May; 127(6):937-944. PubMed ID: 36735183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study.
    Shin DW; Bae J; Ha J; Jung KW
    J Gynecol Oncol; 2021 Jan; 32(1):e5. PubMed ID: 33185046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
    van der Werf LR; Wijnhoven BPL; Fransen LFC; van Sandick JW; Nieuwenhuijzen GAP; Busweiler LAD; van Hillegersberg R; Wouters MWJM; Luyer MDP; van Berge Henegouwen MI
    Ann Surg; 2019 Nov; 270(5):868-876. PubMed ID: 31634182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
    Seesing MFJ; van der Veen A; Brenkman HJF; Stockmann HBAC; Nieuwenhuijzen GAP; Rosman C; van den Wildenberg FJH; van Berge Henegouwen MI; van Duijvendijk P; Wijnhoven BPL; Stoot JHMB; Lacle M; Ruurda JP; van Hillegersberg R;
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31220859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
    Jung HK; Tae CH; Lee HA; Lee H; Don Choi K; Park JC; Kwon JG; Choi YJ; Hong SJ; Sung J; Chung WC; Kim KB; Kim SY; Song KH; Park KS; Jeon SW; Kim BW; Ryu HS; Lee OJ; Baik GH; Kim YS; Jung HY;
    PLoS One; 2020; 15(4):e0231456. PubMed ID: 32275699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional Survival of Esophageal Cancer: An Analysis from the SEER Registry (1988-2011).
    Kim E; Koroukian S; Thomas CR
    J Thorac Oncol; 2015 Oct; 10(10):1490-7. PubMed ID: 26322395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of surgical resection after starting neoadjuvant chemoradiotherapy in patients with esophageal cancer: A population-based cohort study.
    Borggreve AS; van Rossum PSN; Mook S; Haj Mohammad N; van Hillegersberg R; Ruurda JP
    Eur J Surg Oncol; 2019 Oct; 45(10):1919-1925. PubMed ID: 30975447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
    Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 16. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.
    Schlesinger-Raab A; Mihaljevic AL; Egert S; Emeny R; Jauch KW; Kleeff J; Novotny A; Nüssler NC; Rottmann M; Schepp W; Schmitt W; Schubert-Fritschle G; Weber B; Schuhmacher C; Engel J
    Gastric Cancer; 2016 Jul; 19(3):713-22. PubMed ID: 26260874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.
    Chen HS; Hung WH; Ko JL; Hsu PK; Liu CC; Wu SC; Lin CH; Wang BY
    Medicine (Baltimore); 2016 Mar; 95(10):e3018. PubMed ID: 26962818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study.
    Faiz Z; Lemmens VE; Siersema PD; Nieuwenhuijzen GA; Wouters MW; Rozema T; Coebergh JW; Wijnhoven BP
    World J Surg; 2012 Dec; 36(12):2872-8. PubMed ID: 22965535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.